HIMS
xyz:
equity
· Hyperliquid
—
Equity perp — Hyperliquid synthetic derivative. For real-time exchange pricing, turn off the Crypto toggle and search the bare equity ticker.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Mark Price
$27.65
24h Change
+1.95%
Funding (8h)
+0.0043%
Open Interest
108,829
24h Volume
$1.63M
Oracle Price
$27.64
Mark − Oracle
+0.0534%
Prev Day Close
$27.12
As of (UTC)
2026-07-31 21:50:51
Daily candles — last 91 days
Funding rate history — last 7 days (8h cycles)
Positive funding = longs paying shorts (long-crowded). Negative = shorts paying longs (short-crowded).
Peers — same category
| Coin | Mark | 24h % |
|---|---|---|
| SKHX | $1085.00 | +0.82% |
| SNDK | $1209.20 | -9.65% |
| MU | $816.62 | -9.04% |
| DRAM | $49.81 | -5.95% |
| SKHY | $142.18 | -6.18% |
News headlines Yahoo Finance, 1h cache
-
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
2026-07-31 18:51 · Yahoo
-
Here Comes the Next Wave of GLP-1s. They’ll Treat a Lot More Than Obesity.
2026-07-31 16:35 · Yahoo
-
HIMS Stock Eyes 4-Week Losing Streak: Legal Woes Fuel ‘Very High’ Uncertainty As Analyst Sticks To ‘No Moat’ Call
2026-07-31 01:26 · Yahoo
-
Is The Sharp Drop In Hims & Hers Health Stock A Reason To Buy?
2026-07-30 21:38 · Yahoo
-
2 Unprofitable Stocks for Long-Term Investors and 1 We Ignore
2026-07-30 21:25 · Yahoo
-
HIMS Stock in Focus as FTC Lawsuit Takes Aim at Hims & Hers Business Practices
2026-07-30 14:38 · Yahoo
-
Hims & Hers Health (HIMS) Faces FTC Lawsuit Over Health Data And Billing
2026-07-30 12:09 · Yahoo
-
FTC sues Hims & Hers, alleging it shared health data with Meta, Snap
2026-07-29 21:20 · Yahoo
-
Sector Update: Healthcare Stocks Softer Late Afternoon
2026-07-29 19:46 · Yahoo
-
Hims & Hers Stock Plunges After FTC Sues Over Alleged Privacy Violations
2026-07-29 19:28 · Yahoo